{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:26:22Z","timestamp":1790623582313,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Statutory Funds of the Faculty of Health Sciences","award":["K\/ZDS\/004710"],"award-info":[{"award-number":["K\/ZDS\/004710"]}]},{"name":"Jagiellonian University Medical College, Krak\u00f3w, Poland"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.neuropharm.2015.07.037","type":"journal-article","created":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T19:20:16Z","timestamp":1438456816000},"page":"301-307","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"special_numbering":"C","title":["Antidepressant-like effects of ketamine, norketamine and dehydronorketamine in forced swim test: Role of activity at NMDA receptor"],"prefix":"10.1016","volume":"99","author":[{"given":"Kinga","family":"Sa\u0142at","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata","family":"Siwek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Starowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadeusz","family":"Librowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urszula","family":"Drabik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryszard","family":"Gajdosz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0722-1263","authenticated-orcid":false,"given":"Piotr","family":"Popik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2015.07.037_bib1","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/bms.1200081103","article-title":"Studies on the biotransformation of ketamine. 1-identification of metabolites produced in\u00a0vitro from rat liver microsomal preparations","volume":"8","author":"Adams","year":"1981","journal-title":"Biomed. Mass Spectrom."},{"key":"10.1016\/j.neuropharm.2015.07.037_bib2","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1476-5381.1983.tb11031.x","article-title":"The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate","volume":"79","author":"Anis","year":"1983","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.07.037_bib3","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00213-011-2169-8","article-title":"CD-1 and Balb\/cJ mice do not show enduring antidepressant-like effects of ketamine in tests of acute antidepressant efficacy","volume":"215","author":"Bechtholt","year":"2011","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2015.07.037_bib4","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.07.037_bib5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/bja\/53.1.27","article-title":"Pharmacokinetics and analgesic effect of ketamine in man","volume":"53","author":"Clements","year":"1981","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.neuropharm.2015.07.037_bib6","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/00000542-197310000-00003","article-title":"Distribution in the brain and metabolism of ketamine in the rat after intravenous administration","volume":"39","author":"Cohen","year":"1973","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neuropharm.2015.07.037_bib7","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.3109\/00498254.2012.685777","article-title":"Stereoselective and regiospecific hydroxylation of ketamine and norketamine","volume":"42","author":"Desta","year":"2012","journal-title":"Xenobiotica"},{"key":"10.1016\/j.neuropharm.2015.07.037_bib8","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/archgenpsychiatry.2010.90","article-title":"A\u00a0randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression","volume":"67","author":"Diazgranados","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2015.07.037_bib9","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0014-2999(97)01116-3","article-title":"Norketamine, the main metabolite of ketamine, is a non-competitive NMDA receptor antagonist in the rat cortex and spinal cord","volume":"333","author":"Ebert","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.07.037_bib10","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0022-3565(24)37138-1","article-title":"Ro 25-6981, a highly potent and selective blocker of N-methyl-D-aspartate receptors containing the NR2B subunit. Characterization in\u00a0vitro","volume":"283","author":"Fischer","year":"1997","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2015.07.037_bib11","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/479278a","article-title":"Depression drug disappoints","volume":"479","author":"Ledford","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2015.07.037_bib12","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1190287","article-title":"mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists","volume":"329","author":"Li","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2015.07.037_bib13","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1152\/jn.1987.58.2.251","article-title":"Use-dependent block of excitatory amino acid currents in cultured neurons by ketamine","volume":"58","author":"MacDonald","year":"1987","journal-title":"J.\u00a0Neurophysiol."},{"key":"10.1016\/j.neuropharm.2015.07.037_bib14","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.biopsych.2007.05.028","article-title":"Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors","volume":"63","author":"Maeng","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2015.07.037_bib15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0924-977X(92)90034-6","article-title":"Effects of MK-801 and antidepressant drugs in the forced swimming test in rats","volume":"2","author":"Maj","year":"1992","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2015.07.037_bib16","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/0028-3908(85)90128-5","article-title":"Ketamine acts as a non-competitive N-methyl-D-aspartate antagonist on frog spinal cord in\u00a0vitro","volume":"24","author":"Martin","year":"1985","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2015.07.037_bib17","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejphar.2012.11.023","article-title":"Sub-anesthetic concentrations of (R,S)-ketamine metabolites inhibit acetylcholine-evoked currents in alpha7 nicotinic acetylcholine receptors","volume":"698","author":"Moaddel","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.07.037_bib18","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1176\/appi.ajp.2013.13030392","article-title":"Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial","volume":"170","author":"Murrough","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2015.07.037_bib19","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.biopsych.2012.06.022","article-title":"Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression","volume":"74","author":"Murrough","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2015.07.037_bib20","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jad.2014.09.015","article-title":"Shank3 as a potential biomarker of antidepressant response to ketamine and its neural correlates in bipolar depression","volume":"172","author":"Ortiz","year":"2015","journal-title":"J.\u00a0Affect Disord."},{"key":"10.1016\/j.neuropharm.2015.07.037_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(94)90516-9","article-title":"Antidepressant activity of non-competitive NMDA antagonists in a chronic mild stress model of depression","volume":"263","author":"Papp","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.07.037_bib22","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/ALN.0000000000000285","article-title":"(R,S)-ketamine metabolites (R,S)-norketamine and (2S,6S)-hydroxynorketamine increase the mammalian target of rapamycin function","volume":"121","author":"Paul","year":"2014","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neuropharm.2015.07.037_bib23","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.biopsych.2013.01.021","article-title":"Glutamate-based antidepressants: preclinical psychopharmacology","volume":"73","author":"Pilc","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2015.07.037_bib24","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00213-008-1158-z","article-title":"Lack of persistent effects of ketamine in rodent models of depression","volume":"198","author":"Popik","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2015.07.037_bib25","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1038\/sj.bjp.0705359","article-title":"Nicotine and nicotinic receptor antagonists potentiate the antidepressant-like effects of imipramine and citalopram","volume":"139","author":"Popik","year":"2003","journal-title":"Brit. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.07.037_bib26","first-page":"327","article-title":"Behavioral despair in mice: a primary screening test for antidepressants","volume":"229","author":"Porsolt","year":"1977","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"10.1016\/j.neuropharm.2015.07.037_bib27","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.pbb.2013.06.013","article-title":"Evaluation of anxiolytic-like, anticonvulsant, antidepressant-like and antinociceptive properties of new 2-substituted 4-hydroxybutanamides with affinity for GABA transporters in mice","volume":"110","author":"Salat","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2015.07.037_bib28","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0304-3959(98)00269-3","article-title":"Oral ketamine is antinociceptive in the rat formalin test: role of the metabolite, norketamine","volume":"81","author":"Shimoyama","year":"1999","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2015.07.037_bib29","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0014-2999(99)00330-1","article-title":"Antidepressants for the new millenium","volume":"375","author":"Skolnick","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.07.037_bib30","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1017\/neu.2015.14","article-title":"Effect of NMDA receptor antagonists in the tetrabenazine test for antidepressants: comparison to the tail suspension test","volume":"27","author":"Skolnick","year":"2015","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.neuropharm.2015.07.037_bib31","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.tips.2009.09.002","article-title":"Glutamate-based antidepressants: 20 years on","volume":"30","author":"Skolnick","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2015.07.037_bib32","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.neulet.2014.03.067","article-title":"Antidepressant activity in mice elicited by 3-furan-2-yl-N-p-tolyl-acrylamide, a positive allosteric modulator of the alpha7 nicotinic acetylcholine receptor","volume":"569","author":"Targowska-Duda","year":"2014","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2015.07.037_bib33","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s002130050879","article-title":"Antidepressant effects of nicotine in an animal model of depression","volume":"142","author":"Tizabi","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2015.07.037_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(90)90204-J","article-title":"Functional antagonists at the NMDA receptor complex exhibit antidepressant actions","volume":"185","author":"Trullas","year":"1990","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.07.037_bib35","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/bja\/57.2.197","article-title":"Comparative pharmacology of the ketamine isomers. Studies in volunteers","volume":"57","author":"White","year":"1985","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.neuropharm.2015.07.037_bib36","doi-asserted-by":"crossref","first-page":"839","DOI":"10.3109\/00498258709043993","article-title":"Biotransformation of ketamine, (Z)-6-hydroxyketamine, and (E)-6-hydroxyketamine by rat, rabbit, and human liver microsomal preparations","volume":"17","author":"Woolf","year":"1987","journal-title":"Xenobiotica"},{"key":"10.1016\/j.neuropharm.2015.07.037_bib37","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0091-3057(01)00693-1","article-title":"Prolonged effect of an anesthetic dose of ketamine on behavioral despair","volume":"71","author":"Yilmaz","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2015.07.037_bib38","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.biopsych.2012.03.004","article-title":"Relationship of ketamine's plasma metabolites with response, diagnosis, and side effects in major depression","volume":"72","author":"Zarate","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2015.07.037_bib39","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A\u00a0randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2015.07.037_bib40","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1365-2125.2012.04198.x","article-title":"Simultaneous population pharmacokinetic modeling of ketamine and three major metabolites in patients with treatment-resistant bipolar depression","volume":"74","author":"Zhao","year":"2012","journal-title":"Brit. J. Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.07.037_bib41","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.eurpsy.2013.10.005","article-title":"Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex","volume":"29","author":"Zhou","year":"2014","journal-title":"Eur. Psychiatry"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390815300447?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390815300447?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T21:05:33Z","timestamp":1748552733000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390815300447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":41,"alternative-id":["S0028390815300447"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2015.07.037","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antidepressant-like effects of ketamine, norketamine and dehydronorketamine in forced swim test: Role of activity at NMDA receptor","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2015.07.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}